Patent · US Active

Engineered polymerases

US12139727B2 · kind B2 · utility

2Cited by
10References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2022
Grant dateNov 12, 2024
Priority date
Expiry dateMar 25, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07007
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are engineered variants of archaeal, prokaryotic, and eukaryotic polymerases that exhibit enhanced thermostability, enhanced incorporation of 3′ modified nucleotides, and improved uracil-tolerance, in polymerase-catalyzed nucleotide extension reactions relative to wild type polymerase enzymes. Also provided are uses of the engineered polymerases for forming complexed polymerases, forming binding complexes and forming ternary complexes, and uses for conducting nucleic acid sequencing reactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.